Psychiatria pre prax 3/2021
Comparison of new antipsychotics (lurasidone, cariprazine and brexpiprazole) from the clinical point of view
Three new antipsychotics – cariprazine, lurasidone and brexpiprazole – have been introduced to the Czech market in the past two years. This review article aims to compare them from a clinical point of view. It focuses on their basic characteristics including receptors profile, indications and efficacy, dosage including dose-response relationship and, last but not least, on their tolerability and side effects.
Keywords: brexpiprazole, cariprazine, lurasidone, efficacy, side effects, schizophrenia
